GW501516
Also known as: Cardarine
Status
No approved product. Not FDA-approved, and no approved product is listed in this entry's sources. Development was abandoned over safety concerns, and anti-doping and health authorities have publicly warned against its use.
What it is
A PPAR-delta agonist abandoned in development after animal cancer findings.
What published research measured
Development was halted after long-term rodent studies reported cancers across multiple organs. This is the reason for the reported-concerns tier.
Caution
Not FDA-approved, and no approved product is listed in this entry's sources. Development was abandoned over safety concerns, and anti-doping and health authorities have publicly warned against its use.
Source
Tanaka T et al. 2003 — Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle a… · Oliver WR et al. 2001 — A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.